Q2 2023 Holdings
Filed 2023-08-14 | 82 holdings | $323.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ImmunoGen Inc(IMGNEUR) | EQUITIES | 45253H101 | $26.8M | 1,420,000 | 8.3% |
| Merus NV | EQUITIES | N5749R100 | $15.5M | 589,255 | 4.8% |
| Morphic Holding Inc | EQUITIES | 61775R105 | $14.5M | 252,309 | 4.5% |
| Schrodinger Inc(SDGR) | EQUITIES | 80810D103 | $14.3M | 286,169 | 4.4% |
| Krystal Biotech Inc(KRYS) | EQUITIES | 501147102 | $14.0M | 118,941 | 4.3% |
| Intra-Cellular Therapies Inc(ITCIEUR) | EQUITIES | 46116X101 | $12.6M | 198,723 | 3.9% |
| Akero Therapeutics Inc(AKRO) | EQUITIES | 00973Y108 | $11.3M | 241,357 | 3.5% |
| Oric Pharmaceuticals Inc(ORIC) | EQUITIES | 68622P109 | $11.3M | 1,450,822 | 3.5% |
| Akero Therapeutics Inc(AKRO)Call | LONG OPTION CALLS | 00973Y108 | $11.0M | 236,500 | 3.4% |
| MoonLake Immunotherapeutics(MLTX) | EQUITIES | 61559X104 | $10.2M | 200,000 | 3.2% |
| Biogen Idec Inc(BIIB) | EQUITIES | 09062X103 | $7.6M | 26,854 | 2.4% |
| 89bio Inc(ETNBGBP) | EQUITIES | 282559103 | $7.5M | 396,497 | 2.3% |
| Cogent Biosciences Inc(COGT) | EQUITIES | 19240Q201 | $7.3M | 620,000 | 2.3% |
| Aclaris Therapeutics Inc(ACRS)Call | LONG OPTION CALLS | 00461U105 | $6.8M | 651,400 | 2.1% |
| United Therapeutics Corp(UTHR) | EQUITIES | 91307C102 | $6.6M | 30,029 | 2.1% |
| MacroGenics Inc(MGNX) | EQUITIES | 556099109 | $6.5M | 1,215,675 | 2.0% |
| KalVista Pharmaceuticals Inc(KALV) | EQUITIES | 483497103 | $6.5M | 720,508 | 2.0% |
| Veracyte Inc(VCYT) | EQUITIES | 92337F107 | $5.8M | 229,451 | 1.8% |
| Mirati Therapeutics Inc(MRTXEUR)Call | LONG OPTION CALLS | 60468T105 | $5.4M | 150,000 | 1.7% |
| BioCryst Pharmaceuticals Inc(BCRX) | EQUITIES | 09058V103 | $5.4M | 760,904 | 1.7% |
| Terns Pharmaceuticals Inc(TERN) | EQUITIES | 880881107 | $5.2M | 599,668 | 1.6% |
| Poseida Therapeutics Inc(PSTXUSD) | EQUITIES | 73730P108 | $5.2M | 2,945,948 | 1.6% |
| Nuvalent Inc(NUVL) | EQUITIES | 670703107 | $4.9M | 115,067 | 1.5% |
| Gilead Sciences Inc(GILD) | EQUITIES | 375558103 | $4.7M | 60,448 | 1.4% |
| Vertex Pharmaceuticals Inc(VRTX) | EQUITIES | 92532F100 | $4.6M | 13,175 | 1.4% |
| Tela Bio Inc(TELA) | EQUITIES | 872381108 | $4.2M | 416,440 | 1.3% |
| Viking Therapeutics Inc(VKTX) | EQUITIES | 92686J106 | $4.2M | 258,595 | 1.3% |
| Praxis Precision Medicines Inc | EQUITIES | 74006W108 | $4.0M | 3,476,162 | 1.2% |
| Xenon Pharmaceuticals Inc(XENE) | EQUITIES | 98420N105 | $3.8M | 99,756 | 1.2% |
| Mersana Therapeutics IncCall | LONG OPTION CALLS | 59045L106 | $3.6M | 1,100,000 | 1.1% |
| Olema Pharmaceuticals Inc(OLMA) | EQUITIES | 68062P106 | $3.5M | 390,466 | 1.1% |
| Sarepta Therapeutics Inc(SRPT) | EQUITIES | 803607100 | $3.4M | 29,860 | 1.1% |
| Prothena Corporation PLC(PRTA) | EQUITIES | G72800108 | $3.4M | 49,721 | 1.1% |
| Mirati Therapeutics Inc(MRTXEUR) | EQUITIES | 60468T105 | $3.3M | 91,213 | 1.0% |
| Mersana Therapeutics Inc | EQUITIES | 59045L106 | $3.3M | 1,000,000 | 1.0% |
| Insmed Inc(INSM) | EQUITIES | 457669307 | $3.0M | 144,464 | 0.9% |
| Pharvaris NV(PHVS) | EQUITIES | N69605108 | $3.0M | 200,000 | 0.9% |
| ANI Pharmaceuticals Inc(ANIP) | EQUITIES | 00182C103 | $2.9M | 54,041 | 0.9% |
| Phathom Pharmaceuticals Inc(PHAT) | EQUITIES | 71722W107 | $2.9M | 200,000 | 0.9% |
| Cerus Corp(CERS) | EQUITIES | 157085101 | $2.8M | 1,158,265 | 0.9% |
| Mirum Pharmaceuticals Inc(MIRM) | EQUITIES | 604749101 | $2.8M | 106,375 | 0.9% |
| Aclaris Therapeutics Inc(ACRS) | EQUITIES | 00461U105 | $2.3M | 219,229 | 0.7% |
| Incyte Corp(INCY) | EQUITIES | 45337C102 | $2.1M | 34,110 | 0.7% |
| Trevi Therapeutics Inc(TRVI) | EQUITIES | 89532M101 | $2.1M | 885,924 | 0.7% |
| Intellia Therapeutics Inc(NTLA) | EQUITIES | 45826J105 | $2.1M | 50,858 | 0.6% |
| Pliant Therapeutics Inc(PLRX) | EQUITIES | 729139105 | $1.9M | 107,267 | 0.6% |
| Rhythm Pharmaceuticals Inc(RYTM) | EQUITIES | 76243J105 | $1.9M | 116,168 | 0.6% |
| CymaBay Therapeutics Inc(CBAYUSD) | EQUITIES | 23257D103 | $1.8M | 160,000 | 0.5% |
| Ambrx Biopharma Inc | EQUITIES | 02290A102 | $1.6M | 100,000 | 0.5% |
| Cue Biopharma Inc(CUE) | EQUITIES | 22978P106 | $1.5M | 403,402 | 0.5% |